Although the difference was only borderline significant, there were more patients in WHO stage 3 and 4 in the group of patients who started ART with a CD4 count ≤100 cells/μL ( Table 1 ).
← all excerpts
Among patients with sustained viral suppression in a resource-limited setting, CD4 gains are continuous although gender-based differences occur.
1
—
—